FrancophonIA/ELRC3.0 huggingface dataset:
English: Qtrilmet should be discontinued if a serious hypersensitivity reaction is suspected.
Danish: Ved mistanke om en alvorlig overfølsomhedsreaktion skal Qtrilmet seponeres.
English: A total of 534 adult patients with type 2 diabetes mellitus and inadequate glycaemic control on metformin alone (HbA1c ≥ 8% and ≤ 12%), participated in this 24-week randomised, double-blind, active comparator-controlled superiority trial to compare the combination of saxagliptin 5 mg and dapagliflozin 10 mg added concurrently to metformin, versus saxagliptin 5 mg (DPP-4 inhibitor) or dapagliflozin 10 mg (SGLT2 inhibitor) added to metformin.
Danish: I alt 534 voksne patienter med type 2-diabetes mellitus og utilstrækkelig glykæmisk kontrol på monoterapi med metformin (HbA1c ≥ 8 % og ≤ 12 %) deltog i dette randomiserede, dobbeltblindede superioritetsstudie med aktiv komparatorkontrol af 24 ugers varighed, som sammenlignede kombinationen med saxagliptin 5 mg og dapagliflozin 10 mg som tillægsbehandling til metformin versus saxagliptin 5 mg (DPP-4-hæmmer) eller dapagliflozin 10 mg (SGLT2-hæmmer) som tillægsbehandling til metformin.
English: Therapy with saxagliptin 5 mg and dapagliflozin 10 mg in comparison to insulin glargine in patients inadequately controlled on metformin with or without a sulphonylurea
Danish: Behandling med saxagliptin 5 mg og dapagliflozin 10 mg sammenlignet med insulin glargin hos patienter, der ikke er tilstrækkeligt kontrolleret på metformin med eller uden sulfonylurinstof
English: if you have severe joint pain;
Danish: - hvis du har en alvorlig infektion.
English: Very common nausea, vomiting diarrhoea or stomach ache loss of appetite upper respiratory tract infection including: o infection of the upper chest or lungs, o infection of the sinuses with a feeling of pain and fullness behind your cheeks and eyes
Danish: Andre bivirkninger, når du tager Qtrilmet omfatter: Meget almindelig - kvalme, opkastning - diarré eller mavepine - appetitløshed - infektion i de øvre luftveje, herunder: o infektion i det øvre bryst eller lunger o infektion i bihulerne med følelse af smerte og fylde bag dine kinder og øjne (bihulebetændelse) o betændt næse eller hals (nasopharyngitis) (tegn på dette kan omfatte forkølelse eller ondt i halsen)
English: In case of suspected symptoms, the patient should stop taking Qtrilmet and seek immediate medical attention.
Danish: Patienterne skal informeres om at stoppe med at tage Qtrilmet og øjeblikkeligt søge lægehjælp ved symptomer, der kan give mistanke om laktatacidose.
English: A 24-week randomised, double-blind, placebo-controlled study conducted on patients with type 2 diabetes mellitus and inadequate glycaemic control (HbA1c ≥ 7% and ≤ 10.5%) on metformin and dapagliflozin alone, compared the sequential addition of 5 mg saxagliptin to 10 mg dapagliflozin and metformin, to the addition of placebo to 10 mg dapagliflozin and metformin.
Danish: Et randomiseret, dobbeltblindt, placebokontrolleret studie af 24 ugers varighed udført hos patienter med type 2-diabetes mellitus og utilstrækkelig glykæmisk kontrol (HbA1c ≥ 7 % og ≤ 10,5 %) på metformin og dapagliflozin alene sammenlignede den sekventielle tilføjelse af 5 mg saxagliptin til 10 mg dapagliflozin og metformin med tilføjelse af placebo til 10 mg dapagliflozin og metformin.
English: How to take Qtrilmet
Danish: Sådan skal du tage Qtrilmet
English: Qtrilmet 1,000 mg/2.5 mg/5 mg modified-release tablets Macrogol (E1521)
Danish: Qtrilmet 1.000 mg/2,5 mg/5 mg depottabletter: Macrogol (E1521)
English: Pack size of 14, 28, 56 and 196 modified-release tablets in calendar blisters.
Danish: Pakningsstørrelse med 14, 28, 56 og 196 depottabletter i kalenderblister.
English: Diabetic ketoacidosis, seen rarely (may affect up to 1 in 1,000 people) Signs of diabetic ketoacidosis (see also section 2 “Warnings and precautions”): o increased levels of “ketone bodies” seen in your urine or blood tests, o rapid weight loss,
Danish: - Diabetisk ketoacidose, ses sjældent (kan forekomme hos op til 1 ud af 1.000 personer) Tegn på diabetisk ketoacidose (se også punkt 2 “Advarsler og forsigtighedsregler”): o forhøjet niveau af “ketonstoffer”, der ses i urin- eller blodprøver o hurtigt vægttab o kvalme eller opkastning o mavesmerter o udtalt tørst o hurtig og dyb vejrtrækning o forvirring o usædvanlig søvnighed eller træthed o din ånde lugter sødligt, du har en sød eller metallisk smag i munden eller en forandret lugt af din urin eller sved.
English: What Qtrilmet contains The active substances are metformin, saxagliptin and dapagliflozin.
Danish: Qtrilmet indeholder: - Aktive stoffer: metformin, saxagliptin og dapagliflozin.
English: While a causal relationship between dapagliflozin and bladder cancer is unlikely (see sections 4.8 and 5.3), as a precautionary measure, Qtrilmet is not recommended for use in patients concomitantly treated with pioglitazone.
Danish: 4.8 og 5.3), bør Qtrilmet af forsigtighedsmæssige hensyn ikke anvendes til patienter, der er i samtidig behandling med pioglitazon.
English: Add-on therapy with dapagliflozin in patients inadequately controlled on saxagliptin plus metformin
Danish: Tillægsbehandling med dapagliflozin til patienter, der ikke er tilstrækkeligt kontrolleret på saxagliptin plus metformin
English: Therapy with saxagliptin 5 mg and dapagliflozin 10 mg in patients inadequately controlled on metformin
Danish: Behandling med saxagliptin 5 mg og dapagliflozin 10 mg til patienter, der er utilstrækkeligt kontrolleret med metformin
English: Pack size of 14, 28, 56, 60 and 196 modified-release tablets in blisters.
Danish: Pakningsstørrelse med 14, 28, 56, 60 og 196 depottabletter i kalenderblister.
English: If you are not sure, talk to your doctor, pharmacist or nurse before taking Qtrilmet.
Danish: Spørg lægen, apotekspersonalet eller sygeplejersken, før du tager Qtrilmet, hvis du er i tvivl.
English: This medicinal product is contraindicated in patients with GFR < 30 mL/min (see sections 4.3, 4.4, 4.8 and 5.2).
Danish: Dette lægemiddel er kontraindiceret til patienter med GFR < 30 ml/min (se pkt.
English: when already being treated with metformin and saxagliptin and dapagliflozin.
Danish: - når patienten allerede er i behandling med metformin og saxagliptin og dapagliflozin.
English: A 52-week randomised, double-blind, active-controlled, parallel-group study with a blinded 104-week extension compared once daily saxagliptin 5 mg and dapagliflozin 10 mg plus metformin to glimepiride (a sulphonylurea) up-titrated 1-6 mg plus placebo with metformin in T2DM patients with inadequate glycaemic control (HbA1c ≥ 7.5% and ≤ 10.5%) on metformin alone.
Danish: Et 52 ugers randomiseret, dobbeltblindet, aktivt kontrolleret, parallelgruppestudie med en blindet 104 ugers forlængelse sammenlignede én gang dagligt saxagliptin 5 mg og dapagliflozin 10 mg plus metformin med glimepirid (et sulfonylurinstof) optitreret 1-6 mg plus placebo med metformin hos T2DM-patienter med utilstrækkelig glykæmisk kontrol (HbA1c ≥ 7,5 % og ≤ 10,5 %) alene på metformin.
English: Therapy with saxagliptin 5 mg and dapagliflozin 10 mg in comparison to glimepiride in patients inadequately controlled on metformin
Danish: Behandling med saxagliptin 5 mg og dapagliflozin 10 mg i sammenligning med glimepirid hos patienter, som ikke er tilstrækkeligt kontrolleret på metformin
English: A 24-week randomised, double-blind, placebo-controlled study with a 28-week extension compared the sequential addition of 10 mg dapagliflozin to 5 mg saxagliptin and metformin to the addition of placebo to 5 mg saxagliptin (DPP-4 inhibitor) and metformin in patients with type 2 diabetes mellitus and inadequate glycaemic control (HbA1c ≥ 7% and ≤ 10.5%).
Danish: Et 24 ugers randomiseret, dobbeltblindet placebokontrolleret studie med en 28 ugers forlængelse sammenlignede den sekventielle tilføjelse af 10 mg dapagliflozin til 5 mg saxagliptin og metformin med placebo til 5 mg saxagliptin (DPP-4 hæmmer) og metformin hos patienter med type 2-diabetes mellitus og utilstrækkelig glykæmisk kontrol (HbA1c ≥ 7 % og ≤ 10,5 %).
English: Constipation dry mouth pancreatitis
Danish: Obstipation mundtørhed pankreatitis
English: This medicinal product should not be used in patients with moderate to severe renal impairment (patients with GFR < 60 mL/min (see sections 4.4, 4.8, 5.1 and 5.2).
Danish: Dette lægemiddel bør ikke anvendes til patienter med moderat til svært nedsat nyrefunktion (patienter med GFR < 60 ml/min (se pkt.
English: The same recommendations for monitoring of renal function apply to elderly patients as to all patients (see sections 4.2, 4.4, 4.8 and 5.1).
Danish: De samme anbefalinger for monitorering af nyrefunktionen hos ældre patienter gør sig også gældende for alle andre patienter (se pkt.
English: Volume depletion thirst
Danish: Volumendepl etering
English: This medicinal product is not recommended for use in patients at risk of volume depletion (e.g. receiving loop diuretics) (see section 4.5) or who are volume depleted, e.g. due to acute illness (such as acute gastrointestinal illness with nausea, vomiting or diarrhoea).
Danish: 4.5), eller som er volumendepleterede, f.eks. på grund af akut sygdom (såsom akut gastrointestinal sygdom med kvalme, opkastning eller diarré).
English: What Qtrilmet looks like and contents of the pack Qtrilmet 850 mg/2.5 mg/5 mg modified-release tablets are beige, biconvex, 11 x 21 mm oval tablet, with 3005 debossed on one side.
Danish: Qtrilmet 850 mg/2,5 mg/5 mg depottabletter er beige, bikonvekse, 11 x 21 mm ovale tabletter, præget med 3005 på den ene side.
English: Therefore, in keeping with routine care of the diabetic patient, monitoring for skin disorders, such as blistering, ulceration, or rash, is recommended.
Danish: Derfor anbefales det at monitorere for hudlidelser, f.eks. blærer, ulcerationer eller udslæt, i forbindelse med de normale kontroller af diabetespatienter.
English: Dysuria polyuria
Danish: Dysuri polyuri
English: changes in blood tests (changes in the amount of cholesterol or fats in your blood, increases in the amount of red blood cells in your blood or decreases in creatinine renal clearance) rash changes in taste swelling of the hands, ankles or feet (peripheral oedema)
Danish: - træthed - svære ledsmerter (artralgi) - mavepine og fordøjelsesbesvær (dyspepsi) - opkastning, betændelse i maven (mavekatar) - betændelse i mave eller tarme, der normalt skyldes en infektion (gastroenteritis) - hovedpine, muskelsmerter (myalgi) - ændringer i blodprøver (ændringer i mængden af kolesterol eller fedt i dit blod, stigninger i mængden af røde blodlegemer i dit blod eller nedsat udskillelse af kreatinin fra nyrerne) - udslæt - smagsændringer - hævelse af hænder, ankler eller fødder (perifert ødem)
English: Dapagliflozin 10 mg added to saxagliptin 5 mg + metformin
Danish: Dapagliflozin 10 mg i tillæg til saxagliptin
English: Renal function should be assessed: prior to initiation of this medicinal product and regularly thereafter (see sections 4.2, 4.8, 5.1 and prior to initiation of concomitant medicinal products that may reduce renal function and periodically thereafter (see section 4.5);
Danish: Nyrefunktionen skal bestemmes: - inden behandlingsstart med dette lægemiddel og regelmæssigt derefter (se pkt.
English: Qtrilmet 850 mg/2.5 mg/5 mg modified-release tablets Qtrilmet 1,000 mg/2.5 mg/5 mg modified-release tablets
Danish: Qtrilmet 850 mg/2,5 mg/5 mg depottabletter Qtrilmet 1.000 mg/2,5 mg/5 mg depottabletter
English: Lactic acidosis, seen very rarely (may affect up to 1 in 10,000 people) Qtrilmet may cause a very rare, but very serious side effect called lactic acidosis.
Danish: Qtrilmet kan forårsage en meget sjælden, men meget alvorlig bivirkning, der kaldes laktatacidose.
English: Blood creatinine increased blood urea increased weight decreased
Danish: Forhøjet blodkreatinin forhøjet urinstof i blodet vægttab Bivirkninger rapporteret for dapagliflozin.
English: st study, 4.2% for the combination therapy versus 27.9% for glimepiride plus metformin versus 2.9% for dapagliflozin plus metformin; for the 2
Danish: Den samlede forekomst af hypoglykæmi i to 52ugers undersøgelser, der sammenlignede kombinationsbehandling med glimepirid (SU), var: For den første undersøgelse 4,2 % for kombinationsbehandling versus 27,9 % for glimepirid plus metformin versus 2,9 % for dapagliflozin plus metformin; for den anden undersøgelse 18,5 % for kombinationsbehandling versus 43,1 % for glimepirid plus metformin.
English: Do not take Qtrilmet: if you are allergic to metformin, saxagliptin, dapagliflozin, or any of the other ingredients of this medicine (listed in section 6); if you have had a serious allergic reaction to some other medicines used to control your blood sugar, namely: o ‘gliptins' (or DPP-4 inhibitors) - like alogliptin, linagliptin and sitagliptin or, o ‘gliflozins' (or SGLT2 inhibitors) - like canagliflozin and empagliflozin; if you have uncontrolled diabetes, with: o severe hyperglycaemia (very high blood glucose), o nausea, vomiting, diarrhoea, rapid weight loss, o lactic acidosis (see “Risk of lactic acidosis” below),
Danish: - hvis du har haft en alvorlig allergisk reaktion over for nogle andre lægemidler, som du har taget for at kontrollere dit blodsukker, nemlig: o "gliptiner" (eller DPP-4-hæmmere) - såsom alogliptin, linagliptin og sitagliptin eller o "glifloziner" (eller SGLT2-hæmmere) - såsom canagliflozin og empagliflozin.
English: if you have reduced kidney function or liver problems;
Danish: - hvis du har alvorligt nedsat nyrefunktion.
English: Proportion of patients achieving HbA1c < 7% in study MB102129 and study CV181168 The proportion of patients achieving HbA1c < 7.0% at week 24 in the add-on therapy with dapagliflozin 10 mg to saxagliptin 5 mg plus metformin trial was higher in the dapagliflozin 10 mg and saxagliptin 5 mg plus metformin group 38.0% (95% CI [30.9, 45.1]) compared to the placebo plus saxagliptin 5 mg plus metformin group 12.4% (95% CI [7.0, 17.9]).
Danish: Andelen af patienter, der opnåede HbA1c <7,0 % ved uge 24 i tillægsbehandling med dapagliflozin 10 mg til saxagliptin 5 mg plus metformin var højere i dapagliflozin 10 mg og saxagliptin 5 mg plus metformin-gruppen 38,0 % (95 % CI [ 30,9, 45,1]) sammenlignet med placebo plus saxagliptin 5 mg plus metformin-gruppen 12,4 % (95 % CI [7,0, 17,9]).
English: Qtrilmet 850 mg/2.5 mg/5 mg modified-release tablets Qtrilmet 1,000 mg/2.5 mg/5 mg modified-release tablets metformin hydrochloride/saxagliptin/dapagliflozin
Danish: Qtrilmet 850 mg/2,5 mg/5 mg depottabletter Qtrilmet 1.000 mg/2,5 mg/5 mg depottabletter metforminhydrochlorid/saxagliptin/dapagliflozin
English: EU/1/19/1401/015 14 modified-release tablets EU/1/19/1401/016 28 modified-release tablets EU/1/19/1401/017 56 modified-release tablets EU/1/19/1401/018 60 modified-release tablets EU/1/19/1401/019 196 modified-release tablets EU/1/19/1401/020 14 modified-release tablets (calendar blister) EU/1/19/1401/021 28 modified-release tablets (calendar blister) EU/1/19/1401/022 56 modified-release tablets (calendar blister) EU/1/19/1401/023 196 modified-release tablets (calendar blister)
Danish: EU/1/19/1401/015 14 depottabletter EU/1/19/1401/016 28 depottabletter EU/1/19/1401/017 56 depottabletter EU/1/19/1401/018 60 depottabletter EU/1/19/1401/019 196 depottabletter EU/1/19/1401/020 14 depottabletter (kalenderblister) EU/1/19/1401/021 28 depottabletter (kalenderblister) EU/1/19/1401/022 56 depottabletter (kalenderblister) EU/1/19/1401/023 196 depottabletter (kalenderblister)
English: Qtrilmet 850 mg/2.5 mg/5 mg modified-release tablets:
Danish: Qtrilmet 850 mg/2,5 mg/5 mg depottabletter:
English: if you have “type 1 diabetes”.
Danish: - hvis du nogensinde har haft diabetisk koma.
English: EU/1/19/1401/001 14 modified-release tablets EU/1/19/1401/002 28 modified-release tablets EU/1/19/1401/003 56 modified-release tablets EU/1/19/1401/004 60 modified-release tablets EU/1/19/1401/005 196 modified-release tablets EU/1/19/1401/006 14 modified-release tablets (calendar blister) EU/1/19/1401/007 28 modified-release tablets (calendar blister) EU/1/19/1401/008 56 modified-release tablets (calendar blister) EU/1/19/1401/009 196 modified-release tablets (calendar blister)
Danish: EU/1/19/1401/001 14 depottabletter EU/1/19/1401/002 28 depottabletter EU/1/19/1401/003 56 depottabletter EU/1/19/1401/004 60 depottabletter EU/1/19/1401/005 196 depottabletter EU/1/19/1401/006 14 depottabletter (kalenderblister) EU/1/19/1401/007 28 depottabletter (kalenderblister) EU/1/19/1401/008 56 depottabletter (kalenderblister) EU/1/19/1401/009 196 depottabletter (kalenderblister)
English: In the study comparing concomitant therapy of saxagliptin and dapagliflozin with glimepiride in patients inadequately controlled on metformin alone, the decrease in systolic blood pressure at week 52 in the saxagliptin 5 mg and dapagliflozin 10 mg plus metformin group (-2.6 mmHg 95% CI [-4.4, -0.8]) was greater than in the glimepiride plus metformin group (1.0 mmHg 95% CI [-0.9, 2.9]).
Danish: Faldet i systolisk blodtryk ved uge 52 i saxagliptin 5 mg og dapagliflozin 10 mg plus metformin-gruppen (-2,6 mmHg 95 % CI [-4,4, -0,8]) var større end i glimepirid plus metformin-gruppen (1,0 mmHg 95 % Cl [-0,9, 2.9]).
English: Placebo + dapagliflozin 10 mg + metformin
Danish: Placebo + dapagliflozin 10 mg + metformin (N=162)
English: Qtrilmet 1,000 mg/2.5 mg/5 mg modified-release tablets:
Danish: Qtrilmet 1.000 mg/2,5 mg/5 mg depottabletter:
English: EU/1/19/1401/024 14 modified-release tablets EU/1/19/1401/025 28 modified-release tablets EU/1/19/1401/026 56 modified-release tablets EU/1/19/1401/027 60 modified-release tablets EU/1/19/1401/028 196 modified-release tablets
Danish: EU/1/19/1401/024 14 depottabletter EU/1/19/1401/025 28 depottabletter EU/1/19/1401/026 56 depottabletter EU/1/19/1401/027 60 depottabletter EU/1/19/1401/028 196 depottabletter
English: Each tablet contains 1,000 mg of metformin hydrochloride, saxagliptin hydrochloride equivalent to 2.5 mg saxagliptin and dapagliflozin propanediol monohydrate equivalent to 5 mg dapagliflozin.
Danish: Hver tablet indeholder 1.000 mg metforminhydrochlorid, saxagliptinhydrochlorid svarende til 2,5 mg saxagliptin og dapagliflozinpropandiolmonohydrat svarende til 5 mg dapagliflozin.
English: What Qtrilmet is and what it is used for What you need to know before you take Qtrilmet How to take Qtrilmet
Danish: Det skal du vide, før du begynder at tage Qtrilmet Sådan skal du tage Qtrilmet Bivirkninger
English: Qtrilmet 850 mg/2.5 mg/5 mg modified-release tablets
Danish: Qtrilmet 850 mg/2,5 mg/5 mg depottabletter
English: If any of the above apply to you (or if you are not sure), talk to your doctor before taking Qtrilmet.
Danish: Tal med lægen, før du tager Qtrilmet, hvis noget af ovenstående gælder for dig (eller hvis du er i tvivl).
English: EU/1/19/1401/010 14 modified-release tablets EU/1/19/1401/011 28 modified-release tablets EU/1/19/1401/012 56 modified-release tablets EU/1/19/1401/013 60 modified-release tablets EU/1/19/1401/014 196 modified-release tablets
Danish: EU/1/19/1401/010 14 depottabletter EU/1/19/1401/011 28 depottabletter EU/1/19/1401/012 56 depottabletter EU/1/19/1401/013 60 depottabletter EU/1/19/1401/014 196 depottabletter
English: Qtrilmet 850 mg/2.5 mg/5 mg tablets metformin HCl/saxagliptin/dapagliflozin
Danish: Qtrilmet 850 mg/2,5 mg/5 mg tabletter metformin HCl/saxagliptin/dapagliflozin
English: Each tablet contains 850 mg of metformin hydrochloride, saxagliptin hydrochloride equivalent to 2.5 mg saxagliptin and dapagliflozin propanediol monohydrate equivalent to 5 mg dapagliflozin.
Danish: Hver tablet indeholder 850 mg metforminhydrochlorid, saxagliptinhydrochlorid svarende til 2,5 mg saxagliptin og dapagliflozinpropandiolmonohydrat svarende til 5 mg dapagliflozin.
English: In patients where DKA is suspected or diagnosed, treatment with Qtrilmet should be discontinued immediately.
Danish: Qtrilmet skal straks seponeres hos patienter med mistænkt eller diagnosticeret DKA.
English: Co-administration of metformin with: inhibitors of OCT1 (such as verapamil) may reduce efficacy of metformin; inducers of OCT1 (such as rifampicin) may increase gastrointestinal absorption and efficacy of metformin; inhibitors of OCT2 (such as cimetidine, dolutegravir, ranolazine, trimethoprime, vandetanib, isavuconazole) may decrease the renal elimination of metformin and thus lead to an increase in metformin plasma concentration; inhibitors of both OCT1 and OCT2 (such as crizotinib, olaparib) may alter efficacy and renal elimination of metformin.
Danish: - OCT2-hæmmere (såsom cimetidin, dolutegravir, ranolazin, trimethoprim, vandetanib, isavuconazol) kan reducere den renale udskillelse af metformin og dermed medføre en stigning i metforminkoncentrationen i plasma.
English: Qtrilmet 1,000 mg/2.5 mg/5 mg modified-release tablets
Danish: Qtrilmet 1.000 mg/2,5 mg/5 mg depottabletter
English: Qtrilmet is contraindicated in patients with: hypersensitivity to the active substances or to any of the excipients listed in section 6.1, history of a serious hypersensitivity reaction, including anaphylactic reaction, anaphylactic shock, and angioedema, to any dipeptidyl peptidase-4 (DPP-4) inhibitor or to any sodium-glucose co-transporter 2 (SGLT2) inhibitor (see sections 4.4, 4.8 and 6.1); any type of acute metabolic acidosis (such as lactic acidosis, diabetic ketoacidosis) (see sections 4.4 and 4.8); diabetic pre-coma (see section 4.4); severe renal failure (GFR < 30 mL/min) (see sections 4.2, 4.4 and 5.2); acute conditions with the potential to alter renal function such as: o dehydration, o severe infection, o shock; acute or chronic disease which may cause tissue hypoxia such as: o cardiac or respiratory failure, o recent myocardial infarction, o shock; hepatic impairment (see sections 4.2 and 5.2); acute alcohol intoxication, alcoholism (see section 4.5).
Danish: 4.2, 4.4 og 5.2) - akutte tilstande med potentiale til at ændre nyrefunktionen såsom: o dehydrering o svær infektion o shock - akut eller kronisk sygdom, som kan forårsage vævshypoksi såsom: o hjerte- eller respirationssvigt o nyligt overstået myokardieinfarkt o shock - nedsat leverfunktion (se pkt.
English: Common A Uncommon B Rare Very rare Not known
Danish: A Ikke Almindelig almindelig
English: Modified-release tablets
Danish: Depottabletter
English: if you take any of the following medicines: glucocorticoids, beta-2 agonists, diuretics, carbamazepine, dexamethasone, phenobarbital, phenytoin, and rifampicin as they may reduce the effect of Qtrilmet (see “Other medicines and Qtrilmet”);
Danish: - hvis du har alvorlige ledsmerter - hvis du tager pioglitazon for at nedsætte dit blodsukker, kan Qtrilmet måske ikke anbefales til dig - hvis du tager nogen af følgende lægemidler: glucokortikoider, beta-2-agonister, vanddrivende lægemidler (diuretika), carbamazepin, dexamethason, phenobarbital, phenytoin og rifampicin, da de kan nedsætte virkningen af Qtrilmet (se "Brug af anden medicin sammen med Qtrilmet") - hvis du er 75 år eller ældre - hvis blodprøver viser, at mængden af røde blodlegemer i dit blod er for høj.
English: Signs of dehydration: o very dry or sticky mouth, feeling very thirsty, o feeling very sleepy or tired, o passing little or no water (urine), o fast heartbeat.
Danish: - Dehydrering, (tab af for meget væske fra kroppen), ikke almindelig (kan forekomme hos op til 1 ud af 100 personer) Tegn på dehydration: o meget tør eller klæbrig mund, udpræget tørst o udpræget søvnighed eller træthedsfølelse o meget lille eller ingen vandladning (urin) o hurtig hjerterytme.
English: Qtrilmet 1,000 mg/2.5 mg/5 mg tablets metformin HCl/saxagliptin/dapagliflozin
Danish: Qtrilmet 1.000 mg/2,5 mg/5 mg tabletter metformin HCl/saxagliptin/dapagliflozin
English: General disorders and administratio n site conditions
Danish: Ikke kendt administration sstedet
English: Qtrilmet 850 mg/2.5 mg/5 mg modified-release tablets and Qtrilmet 1,000 mg/2.5 mg/5 mg modified-release tablets are available in blister.
Danish: Qtrilmet 850 mg/2,5 mg/5 mg depottabletter og Qtrilmet 1.000 mg/2,5 mg/5 mg depottabletter fås i blisterpakninger.